Brief: Amplia Therapeutics Says Fully Underwritten 2 For 5 Entitlement Offer
April 16 (Reuters) - Amplia Therapeutics Ltd ATX.AX :
* FULLY UNDERWRITTEN 2 FOR 5 ENTITLEMENT OFFER TO RAISE
A$4.27
MILLION
* NEW SHARES ISSUED UNDER ENTITLEMENT OFFER PRICED AT
A$0.055 EACH
Further company coverage: ATX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement